Literature DB >> 12569150

New insights into the pathogenesis of asthma.

Jack A Elias1, Chun Geun Lee, Tao Zheng, Bing Ma, Robert J Homer, Zhou Zhu.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12569150      PMCID： PMC151878          DOI： 10.1172/JCI17748

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  17 in total

1.  Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group.

Authors:  H Milgrom; R B Fick; J Q Su; J D Reimann; R K Bush; M L Watrous; W J Metzger
Journal:  N Engl J Med       Date:  1999-12-23       Impact factor: 91.245

Review 2.  Is Th1 the solution for Th2 in asthma?

Authors:  K G Tournoy; J C Kips; R A Pauwels
Journal:  Clin Exp Allergy       Date:  2002-01       Impact factor: 5.018

Review 3.  The role of Th1/Th2 polarization in mucosal immunity.

Authors:  Markus F Neurath; Susetta Finotto; Laurie H Glimcher
Journal:  Nat Med       Date:  2002-06       Impact factor: 53.440

4.  A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression.

Authors:  Kazuhiro Ito; Sam Lim; Gaetano Caramori; Borja Cosio; K Fan Chung; Ian M Adcock; Peter J Barnes
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-17       Impact factor: 11.205

5.  IL-13-induced chemokine responses in the lung: role of CCR2 in the pathogenesis of IL-13-induced inflammation and remodeling.

Authors:  Zhou Zhu; Bing Ma; Tao Zheng; Robert J Homer; Chun Geun Lee; Israel F Charo; Paul Noble; Jack A Elias
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

6.  Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet.

Authors:  Susetta Finotto; Markus F Neurath; Jonathan N Glickman; Shixin Qin; Hans A Lehr; Francis H Y Green; Kate Ackerman; Kathleen Haley; Peter R Galle; Susanne J Szabo; Jeffrey M Drazen; George T De Sanctis; Laurie H Glimcher
Journal:  Science       Date:  2002-01-11       Impact factor: 47.728

7.  Pulmonary overexpression of IL-9 induces Th2 cytokine expression, leading to immune pathology.

Authors:  Ulla-Angela Temann; Prabir Ray; Richard A Flavell
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

8.  Use of the tetracycline-controlled transcriptional silencer (tTS) to eliminate transgene leak in inducible overexpression transgenic mice.

Authors:  Z Zhu; B Ma; R J Homer; T Zheng; J A Elias
Journal:  J Biol Chem       Date:  2001-04-30       Impact factor: 5.157

9.  A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model.

Authors:  William R Henderson; Li-Ou Tang; Shi-Jye Chu; Shih-Ming Tsao; Gertrude K S Chiang; Falaah Jones; Mechthild Jonas; Chong Pae; Huaijing Wang; Emil Y Chi
Journal:  Am J Respir Crit Care Med       Date:  2002-01-01       Impact factor: 21.405

10.  Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1).

Authors:  C G Lee; R J Homer; Z Zhu; S Lanone; X Wang; V Koteliansky; J M Shipley; P Gotwals; P Noble; Q Chen; R M Senior; J A Elias
Journal:  J Exp Med       Date:  2001-09-17       Impact factor: 14.307
View more
  122 in total

1.  Anti-inflammatory effects of ivermectin in mouse model of allergic asthma.

Authors:  Shuhan Yan; Xinxin Ci; Na Chen; Chi Chen; Xiangchao Li; Xiao Chu; Jianhua Li; Xuming Deng
Journal:  Inflamm Res       Date:  2011-01-29       Impact factor: 4.575

2.  CD44--a sticky target for asthma.

Authors:  Marc E Rothenberg
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

3.  Th2 cytokines IL-4 and IL-13 downregulate paxillin expression in bronchial airway epithelial cells.

Authors:  Gail Ramirez-Icaza; Kamal A Mohammed; Najmunnisa Nasreen; Robert D Van Horn; Joyce A Hardwick; Kerry L Sanders; Jun Tian; Carlos Ramirez-Icaza; Mary T Johnson; Veena B Antony
Journal:  J Clin Immunol       Date:  2004-07       Impact factor: 8.317

Review 4.  Coagulation-dependent mechanisms and asthma.

Authors:  Michael A Matthay; John A Clements
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

5.  Structural and functional characterization of a novel nonglycosidic type I NKT agonist with immunomodulatory properties.

Authors:  Jerome Kerzerho; Esther D Yu; Carolina M Barra; Elisenda Alari-Pahissa; Elisenda Alari-Pahisa; Enrico Girardi; Youssef Harrak; Pilar Lauzurica; Amadeu Llebaria; Dirk M Zajonc; Omid Akbari; A Raúl Castaño
Journal:  J Immunol       Date:  2012-02-01       Impact factor: 5.422

6.  Exploration of early-life candidate biomarkers for childhood asthma using antibody arrays.

Authors:  Haili Xu; Timothy Radabaugh; Zhenqiang Lu; Michael Galligan; Dean Billheimer; Donata Vercelli; Anne L Wright; Terrence J Monks; Marilyn Halonen; Serrine S Lau
Journal:  Pediatr Allergy Immunol       Date:  2016-09-12       Impact factor: 6.377

7.  Induction of the plasminogen activator system by mechanical stimulation of human bronchial epithelial cells.

Authors:  Eric K Chu; Jason Cheng; John S Foley; Brigham H Mecham; Caroline A Owen; Kathleen J Haley; Thomas J Mariani; Isaac S Kohane; Daniel J Tschumperlin; Jeffrey M Drazen
Journal:  Am J Respir Cell Mol Biol       Date:  2006-06-22       Impact factor: 6.914

Review 8.  Transgenic modeling of transforming growth factor-beta(1): role of apoptosis in fibrosis and alveolar remodeling.

Authors:  Chun Geun Lee; Hye-Ryun Kang; Robert J Homer; Geoffrey Chupp; Jack A Elias
Journal:  Proc Am Thorac Soc       Date:  2006-07

9.  T helper 1 cells stimulated with ovalbumin and IL-18 induce airway hyperresponsiveness and lung fibrosis by IFN-gamma and IL-13 production.

Authors:  Nobuki Hayashi; Tomohiro Yoshimoto; Kenji Izuhara; Kiyoshi Matsui; Toshio Tanaka; Kenji Nakanishi
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-31       Impact factor: 11.205

Review 10.  The potential for genetically altered microglia to influence glioma treatment.

Authors:  W Li; R M D Holsinger; C A Kruse; A Flügel; M B Graeber
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-09       Impact factor: 4.388
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.